H.T. Ford

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer

Andreas Makris, T.J. Powles, S. Ashley et al. · Annals of Oncology · 1998 · 318 citations · Full text

Medicine, Oncology, Surgery +14

A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)

Michael Findlay, David Cunningham, A. Norman et al. · Annals of Oncology · 1994 · 260 citations · Full text

Medicine, Oncology, Pharmacology +17

Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-up

Janine Mansi, Douglas F. Easton, U Berger et al. · European Journal of Cancer and Clinical Oncology · 1991 · 206 citations

Medicine, Oncology, Pathology +14

PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST

David Cunningham, A. Pople, H.T. Ford et al. · The Lancet · 1987 · 192 citations

Medicine, Pharmacology, Pharmacotherapy +9

Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer.

J C Gazet, H.T. Ford, R. Charles Coombes et al. · PubMed · 1994 · 171 citations

Medicine, Geriatric Medicine, Oncology +12